0      0


CT-1.5-SY26 - Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon Receptor Triagonist—Obesity, NAFLD, and T2D Phase 2 Trial Results (Includes Livestream)


‐ Jun 26, 2023 3:00pm


Speaker(s):

You must be logged in and own this session in order to post comments.